Evaluation of depression screening on the uptake of collaborative depression care in Coronary Heart Disease Patients: A Stepped-Wedge Randomized Controlled Trial

The University of Adelaide0 个研究点目标入组 756 人开始时间: 2020年12月2日最近更新: 2020年12月7日

适应症

试验速览

暂无简介。

•1) aged greater than or equal to 18 years.
•2) able to communicate in English.
•3) CHD out-patient with history of any; acute coronary syndrome [ST and non-ST elevation myocardial infarction, unstable angina], percutaneous coronary intervention or coronary artery bypass graft, or other clinical indication of CHD e.g. greater than or equal to 50% stenosis in 1 coronary artery from coronary angiography.
•4) have a moderate to severe level of depression denoted as a PHQ-9 depression screening score greater than or equal to 10

•1) already receiving current antidepressant, psychotherapy, or psychiatric care.
•2) have a complex psychiatric comorbidity including any psychosis, bi-polar disorder, personality disorder, drug or alcohol dependence, as defined by medical records or self-report.
•3) high suicide risk requiring acute psychiatric assessment via a referral to the emergency department, determined as a severe level of depression and a positive response to PHQ suicidality item more than half the days” or higher.
•4) observed cognitive impairment or dementia (e.g. donepezil use) impeding delivery of collaborative care components such as psychotherapy.
•5) severe non-vascular comorbidity with life expectancy <12 months.

发起方